Exercise Conditions

Exercise Conditions. On or after the Exercisability Date, the Closing Sale Price per share of the Common Stock is greater than or equal to one dollar ($1.00) (as adjusted for splits, recapitalization and the like) for a period of ten (10) out of twenty (20) consecutive Trading Days following the date that is six months after the closing date of the offering pursuant to which the Company was obligated to issue this Warrant, provided, however, that: i) during the twenty (20) Trading Day period referred to in... this Section 17(f), the Common Stock must trade at an average dollar-volume of at least $50,000 per Trading Day; and ii) either: 1. a Registration Statement (as defined in that certain Registration Rights Agreement, dated as of the hereof, between the Company, the Holder and the other signatories thereto (the "RRA")) or Registration Statements covering all of the Registrable Securities (as defined in the RRA) shall have been filed with and declared effective under the Securities Act by the U.S. Securities and Exchange Commission and shall have remained continuously effective under the Securities Act during the entire twenty (20) consecutive Trading Day period referred to in this Section 17(f); or 2. the Holder shall have been permitted to sell all of the Registrable Securities held by such Holder pursuant to Rule 144 under the Securities Act during the entire twenty (20) consecutive Trading Day period referred to in this Section 17(f). View More

Exercise Conditions. All of the following conditions (i) the Closing Sale Price per share of the Common Stock is greater than or equal to thirty dollars ($30.00) (as adjusted for splits, recapitalization and the like) for a consecutive period of thirty-one (31) trading days and (ii) the average daily trading volume for the shares of Common Stock over the same 31-day period referenced in (i) above equals or exceeds 65,000 shares

Exercise Conditions. The Company's achievement of consolidated trailing twelve-month Adjusted EBITDA of $12 million for any twelve month period during the term of the Warrant.

Exercise Conditions. Means the occurrence of the closing price of the Company's Common Stock on an Eligible Market equaling or exceeding 200% of the Exercise Price for at least 40 consecutive Trading Days.

Exercise Conditions. Means the public announcement of top-line data from the Company's randomized withdrawal period of Study C602 stating that the primary endpoint of change from baseline in hyperphagia, defined as statistically significant with a p<0.05, was met and no new significant safety signals were identified. Such public announcement must contain a statement that the Company intends to submit a New Drug Application for DCCR based on the data obtained from the randomized withdrawal period of Study C602.

Exercise Conditions. Means that the Company's receipt of the Food and Drug Administration's marketing approval for DCCR (Diazoxide Choline) Extended-Release tablets for the treatment of Prader-Willi syndrome (PWS).